Owen N. Vickery

Owen N. Vickery

Auto-generated profile, based on publicly available information

Owen N. Vickery

Department of Biochemistry, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2018 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
WKWojciech Kopec
Wojciech Kopec
DKDavid A. Köpfer
David A. Köpfer
OVOwen N. Vickery
Owen N. Vickery
ABAnna S. Bondarenko
Anna S. Bondarenko
TJThomas L. C. Jansen
Thomas L. C. Jansen
UZUlrich Zachariae
Ulrich Zachariae

14 September 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
JDJustin C. Deme
Justin C. Deme
SJSteven Johnson
Steven Johnson
OVOwen Vickery
Owen Vickery
AAAmy Aron
Amy Aron
HMHolly Monkhouse
Holly Monkhouse
SLSusan M. Lea
Susan M. Lea

1 June 2016 in Structure
Verified
Journal Article
Open access
OVOwen N. Vickery
Owen N. Vickery
JMJan-Philipp Machtens
Jan-Philipp Machtens
GTGiulia Tamburrino
Giulia Tamburrino
DSDaniel Seeliger
Daniel Seeliger
UZUlrich Zachariae
Ulrich Zachariae
G-protein-coupled receptors (GPCRs) form the largest superfamily of membrane proteins and one-third of all drug targets in humans. A number of recent studies have reported evidence for substantial voltage regulation of GPCRs. However, the structural basis of GPCR voltage sensing has remained enigmatic. Here, we present atomistic simulations on the δ-opioid and M2 muscarinic receptors, which suggest a structural and mechanistic explanation for the observed voltage-induced functional effects. The simulations reveal that the position of an internal Na(+) ion, recently detected to bind to a highly conserved aqueous pocket in receptor crystal structures, strongly responds to voltage changes. The movements give rise to gating charges in excellent agreement with previous experimental recordings. Furthermore, free energy calculations show that these rearrangements of Na(+) can be induced by physiological membrane voltages. Due to its role in receptor function and signal bias, the repositioning of Na(+) has important general implications for signal transduction in GPCRs.

1 October 2016 in Current Opinion in Pharmacology
Verified
Journal Article
Open access
OVOwen N Vickery
Owen N Vickery
JMJan-Philipp Machtens
Jan-Philipp Machtens
UZUlrich Zachariae
Ulrich Zachariae
G-protein coupled receptors (GPCRs) form the largest class of membrane proteins in humans and the targets of most present drugs. Membrane potential is one of the defining characteristics of living cells. Recent work has shown that the membrane voltage, and changes thereof, modulates signal transduction and ligand binding in GPCRs. As it may allow differential signalling patterns depending on tissue, cell type, and the excitation status of excitable cells, GPCR voltage sensitivity could have important implications for their pharmacology. This review summarises recent experimental insights on GPCR voltage regulation and the role of molecular dynamics simulations in identifying the structural basis of GPCR voltage-sensing. We discuss the potential significance for drug design on GPCR targets from excitable and non-excitable cells.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ALAngharad Lloyd
Angharad Lloyd
OVOwen N. Vickery
Owen N. Vickery
BLBruno Laugel
Bruno Laugel
Recent early stage clinical trials evaluating the adoptive transfer of patient CD8+ T-cells re-directed with antigen receptors recognizing tumors have shown very encouraging results. These reports provide strong support for further development of the therapeutic concept as a curative cancer treatment. In this respect combining the adoptive transfer of tumor-specific T-cells with therapies that increase their anti-tumor capacity is viewed as a promising strategy to improve treatment outcome. The ex vivo genetic engineering step that underlies T-cell re-direction offers a unique angle to combine antigen receptor delivery with the targeting of cell-intrinsic pathways that restrict T-cell effector functions. Recent progress in genome editing technologies such as protein- and RNA-guided endonucleases raise the possibility of disrupting gene expression in T-cells in order to enhance effector functions or to bypass tumor immune suppression. This approach would avoid the systemic administration of compounds that disrupt immune homeostasis, potentially avoiding autoimmune adverse effects, and could improve the efficacy of T-cell based adoptive therapies.

11 April 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
CHChristopher J. Holland
Christopher J. Holland
BMBruce J. MacLachlan
Bruce J. MacLachlan
VBValentina Bianchi
Valentina Bianchi
SHSophie J. Hesketh
Sophie J. Hesketh
RMRichard Morgan
Richard Morgan
DCDavid K. Cole
David K. Cole
T-cell immunity is controlled by T-cell receptor (TCR) binding to peptide major histocompatibility complexes (pMHCs). The nature of the interaction between these two proteins has been the subject of many investigations because of its central role in immunity against pathogens, cancer, in autoimmunity, and during organ transplant rejection. Crystal structures comparing unbound and pMHC-bound TCRs have revealed flexibility at the interaction interface, particularly from the perspective of the TCR. However, crystal structures represent only a snapshot of protein conformation that could be influenced through biologically irrelevant crystal lattice contacts and other factors. Here, we solved the structures of three unbound TCRs from multiple crystals. Superposition of identical TCR structures from different crystals revealed some conformation differences of up to 5Å in individual CDR loops that are similar to those that have previously been attributed to antigen engagement. We then used combination of rigidity analysis and simulations of protein motion to reveal the theoretical potential of TCR CDR loop flexibility in inbound state. These simulations of protein motion support the notion that crystal structures may only offer an artefactual indication of TCR flexibility, influenced by crystallization conditions and crystal packing that is inconsistent with the theoretical potential of intrinsic TCR motions.